Deutsche Bank
STLN

Deutsche Bank’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Deutsche Bank’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Buy
55,922
+8,074
+17% +$24.8K ﹤0.01% 3065
2025
Q4 		$170K Sell
47,848
-40,633
-46% -$151K ﹤0.01% 3090
2025
Q3 		$309K Buy
88,481
+86,846
+5,312% +$298K ﹤0.01% 2833
2025
Q2 		$3.35K Buy
+1,635
New +$4.09K ﹤0.01% 3552
2024
Q2 		– Sell
-9,435
Closed -$14.9K – 3696
2024
Q1 		$14.9K Hold
9,435
– – ﹤0.01% 3517
2023
Q4 		$19.2K Hold
9,435
– – ﹤0.01% 3497
2023
Q3 		$13.2K Sell
9,435
-10,936
-54% -$11.3K ﹤0.01% 3539
2023
Q2 		$11.2K Sell
20,371
-572
-3% -$303 ﹤0.01% 3642
2023
Q1 		$14.2K Buy
20,943
+5,571
+36% +$7.11K ﹤0.01% 3747
2022
Q4 		$25.4K Buy
15,372
+230
+2% +$646 ﹤0.01% 3735
2022
Q3 		$70K Buy
15,142
+5,695
+60% +$33.5K ﹤0.01% 3485
2022
Q2 		$48K Buy
+9,447
New +$68.8K ﹤0.01% 3768
2021
Q4 		– Sell
-500,000
Closed -$4.97M – 4403
2021
Q3 		$4.97M Sell
500,000
-80,308
-14% -$797K ﹤0.01% 1501
2021
Q2 		$5.77M Sell
580,308
-16,334
-3% -$164K ﹤0.01% 1439
2021
Q1 		$5.94M Sell
596,642
-100,386
-14% -$1.07M ﹤0.01% 1454
2020
Q4 		$7.53M Sell
697,028
-100,000
-13% -$1.03M ﹤0.01% 1161
2020
Q3 		$8.27M Hold
797,028
– – 0.01% 1040
2020
Q2 		$8.01M Buy
+797,028
New +$7.93M 0.01% 1072

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's STLN Position: Q1 2026 in Review

Deutsche Bank increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 17% in Q1 2026, buying an estimated $24.8K and bringing the position to 55,922 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

Deutsche Bank first reported a position in STLN in Q2 2020 and has held it in 18 quarters since. The position peaked at $8.27M in Q3 2020. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Deutsche Bank held 55,922 shares of Starling Oncology Institute, Inc. Common Stock worth $172K as of Q1 2026.
  • Deutsche Bank bought 8,074 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $24.8K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3065 holding.
  • Deutsche Bank first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2020 and has held it in 18 quarters since.
  • Deutsche Bank's Starling Oncology Institute, Inc. Common Stock position peaked at $8.27M in Q3 2020.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.